A group of 20 early-stage life sciences startups in Washington each received $25,000 grants, part of an effort to fuel the “next generation” of life science innovation in the state.… Read More
Join Madrona Venture Group Investor Joe Horsman and WRF Capital Managing Director, Will Canestaro, for an in-person Lunch and Learn session hosted by Life Science Washington Institute on the current… Read More
Seattle biotech startup A-Alpha Bio raised $22.4 million to boost development of its machine learning platform that analyzes protein-protein interactions. A-Alpha Bio, a spinout of the Institute for Protein Design… Read More
Affini-T Therapeutics, a cell therapy company spun out of Fred Hutchinson Cancer Research Center that aims to treat solid tumors, is closing its Seattle lab.
Swiss biopharma giant Novartis announced Monday it plans to buy Seattle-based Chinook Therapeutics for $3.2 billion, marking another blockbuster acquisition for the biotech industry in the Seattle region. Founded in… Read More
Seattle biotech startup Immusoft has received approval to begin clinical trials of its novel strategy for treating genetic disease, the company announced Thursday. Immusoft says it’s the first to get… Read More
Tech startups in Seattle and the Pacific Northwest raised less than $4 billion in funding in the first half of 2022, down 20% from more than $5 billion in the… Read More
Biotech is coming off an epic few years. The sector soared during the pandemic, with venture capital investment and IPO volumes hitting all-time highs. But recently stock valuations have plummeted,… Read More
Hans Bishop and Steve Harr know a few things about biotech. The pair once worked together at Seattle flagship cell therapy company Juno Therapeutics, where Bishop was CEO and Harr… Read More
Absci, the Vancouver, Wash.-based biotech that provides drug and drug target discovery services to other companies, has opened a lab in New York City. The company announced the opening of… Read More
Leen Kawas, the Seattle biotech exec who resigned as CEO of Athira Pharma after an investigation found she had altered doctoral research images that helped to form the initial basis… Read More
Kenneth Galbraith is shaking up Zymeworks within a week of becoming CEO of the Seattle and Vancouver, B.C.-based biotech company. He announced major leadership changes in a statement Wednesday, and… Read More
Looking at GeekWire’s most-read stories for 2021, this series of headlines stands out as a symbol of the past year, not just for Amazon but for the world at large.… Read More
It’s hard for life sciences startups to find lab space, and there’s a good reason. The sector has been on a tear, according to a report tallying venture capital and… Read More
The news: Chinook Therapeutics on Tuesday announced the formation of SanReno Therapeutics, which will advance therapies for kidney disease in China, Hong Kong, Macau, Taiwan and Singapore. SanReno is a… Read More
Absci cut the ribbon on its new headquarters in Vancouver, Wash., on Tuesday, barely three months after going public in an IPO that valued the biotech company at nearly $2… Read More
Joel Marcus’ fortunes have risen with those of the life sciences industry. The executive chairman of life sciences builder Alexandria Real Estate Equities first bought laboratory space in Seattle in… Read More
Leslie Alexandre has seen a lot from her perch surveying Washington state’s life sciences landscape. She is set to retire at the end of this year after five years as… Read More
Alpine Immune Sciences will move a potential treatment for immune conditions into human testing and support its ongoing trials for cancer thanks to around $91 million in new funding. The… Read More
In the past several years the barriers between tech and the life sciences have begun to dissolve. AI and machine learning have gone from buzzwords to bedrock technologies for a… Read More
In a region better known for its tech startups and legions of software engineers, it’s biotech companies that have helped lead a recent IPO boom in the state of Washington,… Read More
The Seattle area is home to a new nimble drug manufacturing facility built by Just – Evotec Biologics that was unveiled Wednesday in an opening ceremony at the 130,000 square-foot… Read More
At home and at work, Justine Dell’Aringa is up for a challenge. The scientific associate director of Translational Research for Bristol Myers Squibb’s Immuno-Oncology and Cell Therapy Thematic Research Center… Read More
Shares of Absci surged more than 30% on Thursday as the Vancouver, Wash.-based biotech company made its debut as a public company. Absci priced its stock at $16 per share… Read More
Shape Therapeutics, a Seattle preclinical stage biotech company developing RNA editing and gene therapy technologies, has raised $112 million. The company’s RNA editing technologies are spun out of the lab… Read More
New funding: Just seven months after announcing a $53 million Series A round, Umoja Biopharma has raised an additional $210 million in a Series B round. The company is developing… Read More
New funding: Seattle biotech startup Oisín Biotechnologies has raised a $5 million seed round. It’s currently developing preclinical therapies that target and kill damaged cells that have been biologically turned… Read More
New funding: Gene-sequencing startup TwinStrand Biosciences raised $50 million in a Series B round led by Section 32, a California-based fund focused on biotech, technology, healthcare and life sciences. Total… Read More
New funding: At a moment when vaccines are on everyone’s mind, a Seattle-based biotech company that has an unusual approach to vaccine production has raised $100 million in a Series… Read More
